8-K-ALAN LEVIN DEPARTURE
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_______________________________
FORM 8-K
_______________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): June 4, 2013 (May 29, 2013)
_______________________________
ENDO HEALTH SOLUTIONS INC.
(Exact Name of Registrant as Specified in Its Charter)
_______________________________
|
| | |
Delaware | 001-15989 | 13-4022871 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
|
| |
1400 Atwater Drive, Malvern, Pennsylvania | 19355 |
(Address of principal executive offices) | (Zip Code) |
Registrant's telephone number, including area code (484) 216-0000
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| |
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On May 29, 2013, Endo Health Solutions Inc. (the Company) announced that Alan G. Levin, 51, the Company's Executive Vice President and Chief Financial Officer will be leaving the Company. Mr. Levin will continue to serve in his present position until the fall of 2013 or earlier upon the appointment of his successor. The Board of Directors is conducting an external search for the Company's next Chief Financial Officer with the assistance of a leading executive search firm.
A copy of the press release announcing Mr. Levin's departure is furnished as Exhibit 99.1.
| |
Item 9.01. | Financial Statements and Exhibits. |
| |
(a) | Financial Statements of Business Acquired. |
Not applicable.
| |
(b) | Pro Forma Financial Information. |
Not applicable.
| |
(c) | Shell Company Transactions. |
Not applicable.
|
| | |
Exhibit Number | | Description |
99.1 | | Press Release announcing departure of Chief Financial Officer |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
| |
| |
ENDO HEALTH SOLUTIONS INC. |
(Registrant) |
| |
By: | /s/ CAROLINE B. MANOGUE |
Name: | Caroline B. Manogue |
Title: | Executive Vice President, Chief Legal Officer & Secretary |
Dated: June 4, 2013
INDEX TO EXHIBITS
|
| | |
Exhibit Number | | Description |
99.1 | | Press Release announcing departure of Chief Financial Officer |